Effects of mutations in an HIV-1 gag gene containing a 107-codon tandem repeat in the matrix region on assembly and processing of the protein product

Journal of Medical Virology

Volumn 74, Issue 4, 2004, Pages 528-535

  Liao, Wei Hao ^b   Chiu, Hsu Chen ^b   Wang, Chin Tien ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NONE

Author keywords

Gag; Human immunodeficiency virus; Matrix mutants

Indexed keywords

GAG PROTEIN; MATRIX PROTEIN; VIRUS PROTEIN;

ARTICLE; CELL BUDDING; CELLULAR DISTRIBUTION; CODON; CORRELATION ANALYSIS; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PROTEIN EXPRESSION; TANDEM REPEAT; VIRUS INFECTION; VIRUS PARTICLE;

CELL CULTURE TECHNIQUES; CODON; GENE PRODUCTS, GAG; HIV-1; HUMANS; MUTATION; TANDEM REPEAT SEQUENCES; TRANSFECTION; VIRAL MATRIX PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 7044222138     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20209     Document Type: Article

References (36)

1. Bryant M, Ratner L. 1990. Myristylation-dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci USA 87:523-527.
2. Cannon PM, Matthews S, Clark N, Byles ED, Iourin O, Hockley DJ, Kingsman SM, Kingsman AJ. 1997. Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol 71:3474-3483.
3. Chen SW, Chiu HC, Liao WH, Wang FD, Chen SL, Wang CT. 2004. The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particle. Virology 318:534-541.
4. Cosson P. 1996. Direct interaction between the envelope and matrix proteins of HIV-1. EMBO J 15:5783-5788.
5. Dorfman T, Mammano F, Haseltine WA, Gottlinger HG. 1994. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol 68:1689-1696.
6. Freed EO. 1998. HIV Gag protein: Diverse functions in the virus life cycle. Virology 251:2-15.
7. Freed EO, Martin MA. 1995. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific single amino acid substitution in the human immunodeficiency virus type 1 matrix. J Virol 69:1984-1989.
8. Freed EO, Orenstein JM, Buckler-White AJ, Martin MA. 1994. Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol 68:5311-5320.
9. Gottlinger HG, Sodroski JG, Haseltine WA. 1989. Role of capsid precursor processing and myristylation in morphogenesis and infectivity of human immunodeficiency virus type1. Proc Natl Acad Sci USA 86:5781-5785.
10. Graham R, van der Eb A. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
11. Henderson LE, Bowers MA, Sowder RC II, Serabyn SA, Johnson DG, Bess JW, Jr., Arthur LO, Bryant DK, Fenselau C. 1992. Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: Posttranslational modifications, proteolytic processing, and complete amino acid sequences. J Virol 66:1856-1865.
12. Hunter E. 1994. Macromolecular interactions in the assembly of HIV and other retroviruses. Semin Virol 5:71-83.
13. Kaplan AH, Manchester M, Swanstorm R. 1994. The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release to occur with maximum efficiency. J Virol 68:6782-6786.
14. Kohl NE, Emini EA, Schleif WE, Davis EJ, Heimbach JC, Dixon RAF, Scolnick EM, Sigal IS. 1988. Active human immunodeficiency virus protease is required for viral infectivity. Proc Natl Acad Sci USA 85:4686-4690.
15. Leis J, Baltimore DJ, Bisthop B, Coffin J, Fleissner E, Goff SP, Oroszlan S, Robinson H, Skalka AM, Temin HM, Vogt V. 1988. Standardized and simplified nomenclature for proteins common to all retroviruses. J Virol 62:1808-1809.
16. Lodge R, Gottlinger H, Gabuzda D, Cohen EA, Lemay G. 1994. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells. J Virol 68:4857-4861.
17. Massiah MA, Starich MR, Paschall C, Summers MF, Christensen AM, Sundquist WI. 1994. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. J Mol Biol 244:198-223.
18. Mervis RJ, Ahmad N, Lillehoj EP, Raum MG, Salazar FHR, Chan HW, Venkatesan S. 1988. The gag gene products of human immunodeficiency virus type 1: Alignment within the gag open reading frame, identification of posttranslational modification, and evidence for alternative gag precursors. J Virol 62:3993-4002.
19. Ono A, Freed EO. 1999. Binding of human immunodeficiency virus type 1 gag to membrane: Role of the matrix amino terminus. J Virol 73:4136-4144.
20. Ono A, Orenstein JM, Freed EO. 2000. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly. J Virol 74:2855-2866.
21. Page KA, Landau NR, Littman DR. 1990. Construction and use of a human immunodeficiency virus: Vector for analysis of virus infectivity. J Virol 64:5270-5276.
22. Pal R, Reitz MS, Jr., Tschanchler E, Gallo RC, Sarngadharan MG, Veronese FDM. 1990. Myristylation of gag proteins of HIV-1 plays an important role in virus assembly. AIDS Res Hum Retroviruses 6:721-730.
23. Peng C, Ho BK, Chang TW, Chang NT. 1989. Role of human immunodeficiency virus type 1-specific protease in core particle maturation and viral infectivity. J Virol 63:2550-2556.
24. Ratner L, Haseltine W, Patarea R, Liva KJ, Starcich B, Josephs SF, Doran ER, Rlfalski JA, Whitehorn EA, Baumeister K, Ivanoff L, Petteway SR, Jr., Pearson ML, Lautenberger JA, Papas TS, Ghrayeb J, Chang NT, Gallo RC, Wong-Staal F. 1985. Complete nucleotide sequences of the AIDS virus, HTLV-III. Nature 313:277-284.
25. Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, Goff SP. 1995. Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: Effects on virion particle assembly, release, and infectivity. J Virol 69:642-650.
26. Sambrook J, Russell DW. 2001. Molecular cloning: A laboratory manual, 3rd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory.
27. Spearman P, Wang JJ, Heyden NV, Ratner L. 1994. Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol 68:3232-3242.
28. Wang CT, Barklis E. 1993. Assembly, processing, and infectivity of human immunodeficiency virus type 1 Gag mutants. J Virol 67:4264-4273.
29. Wang CT, Zhang Y, McDermott J, Barklis E. 1993. Conditional infectivity of a human immunodeficiency virus matrix domain deletion mutant. J Virol 67:7067-7076.
30. Wang CT, Lai HY, Li JJ. 1998. Analysis of minimal human immunodeficiency virus type 1 (HIV-1) gag coding sequences capable of virus-like particle assembly and release. J Virol 72:7950-7959.
31. Wang CT, Chen SL, Chiang CC. 2000a. Assembly and release of human immunodeficiency virus type 1 Gag proteins containing tandem repeats of the matrix coding sequences in the matrix domain. Virology 278:289-298.
32. Wang CT, Chou YC, Chiang CC. 2000b. Assembly and processing of human immunodeficiency virus gag mutants containing a partial replacement of the matrix domain by the viral protease domain. J Virol 74:3418-3422.
33. Wang CT, Yang AH, Chiang CC. 2000c. Analysis of a human immunodeficiency virus type 1 Gag mutant with an engineered 110-amino-acid insertion in the matrix protein domain. J Med Virol 61:423-432.
34. Wills JW, Craven RC. 1991. Form, function, and use of retroviral gag proteins. AIDS 5:639-654.
35. Yuan X, Yu X, Lee TH, Essex M. 1993. Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol 67:6387-6394.
36. Zhou W, Resh MD. 1996. Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol 70:8640-8648.